Market Analysis and Insights: Global Sanger’s Sequencing Service Market
The global Sanger’s Sequencing Service market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Sanger’s Sequencing Service market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Sanger’s Sequencing Service market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Sanger’s Sequencing Service market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Sanger’s Sequencing Service market.
Sanger’s Sequencing Service Breakdown Data by Type
Diagnostics
Biomarkers & Cancer
Reproductive Health
Personalized Medicine
Forensics
Others
Sanger’s Sequencing Service Breakdown Data by Application
Academic & Government Research Institutes
Pharmaceutical Companies
Biotechnology Companies
Hospitals & Clinics
Based on regional and country-level analysis, the Sanger’s Sequencing Service market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Sanger’s Sequencing Service market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The following players are covered in this report:
Source BioScience (UK)
GenScript Biotech Corporation (US)
Thermo Fisher Scientific, Inc. (US)
LGC Science Group Limited (UK)
Fasteris SA (Switzerland)
CeMIA SA (Greece)
Quintara Biosciences (US)
GenHunter Corporation (US)
GENEWIZ (US)
Nucleics (Australia)
SciGenom Labs Pvt. Limited (Inida)
Microsynth AG. Inc. (Germany)
The global Sanger’s Sequencing Service market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Sanger’s Sequencing Service market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Sanger’s Sequencing Service market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Sanger’s Sequencing Service market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Sanger’s Sequencing Service market.
Sanger’s Sequencing Service Breakdown Data by Type
Diagnostics
Biomarkers & Cancer
Reproductive Health
Personalized Medicine
Forensics
Others
Sanger’s Sequencing Service Breakdown Data by Application
Academic & Government Research Institutes
Pharmaceutical Companies
Biotechnology Companies
Hospitals & Clinics
Based on regional and country-level analysis, the Sanger’s Sequencing Service market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Sanger’s Sequencing Service market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The following players are covered in this report:
Source BioScience (UK)
GenScript Biotech Corporation (US)
Thermo Fisher Scientific, Inc. (US)
LGC Science Group Limited (UK)
Fasteris SA (Switzerland)
CeMIA SA (Greece)
Quintara Biosciences (US)
GenHunter Corporation (US)
GENEWIZ (US)
Nucleics (Australia)
SciGenom Labs Pvt. Limited (Inida)
Microsynth AG. Inc. (Germany)
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sanger’s Sequencing Service Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Diagnostics
1.2.3 Biomarkers & Cancer
1.2.4 Reproductive Health
1.2.5 Personalized Medicine
1.2.6 Forensics
1.2.7 Others
1.3 Market by Application
1.3.1 Global Sanger’s Sequencing Service Market Share by Application: 2020 VS 2026
1.3.2 Academic & Government Research Institutes
1.3.3 Pharmaceutical Companies
1.3.4 Biotechnology Companies
1.3.5 Hospitals & Clinics
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Sanger’s Sequencing Service Market Perspective (2015-2026)
2.2 Global Sanger’s Sequencing Service Growth Trends by Regions
2.2.1 Sanger’s Sequencing Service Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Sanger’s Sequencing Service Historic Market Share by Regions (2015-2020)
2.2.3 Sanger’s Sequencing Service Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sanger’s Sequencing Service Players by Market Size
3.1.1 Global Top Sanger’s Sequencing Service Players by Revenue (2015-2020)
3.1.2 Global Sanger’s Sequencing Service Revenue Market Share by Players (2015-2020)
3.2 Global Sanger’s Sequencing Service Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Sanger’s Sequencing Service Revenue
3.4 Global Sanger’s Sequencing Service Market Concentration Ratio
3.4.1 Global Sanger’s Sequencing Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sanger’s Sequencing Service Revenue in 2019
3.5 Key Players Sanger’s Sequencing Service Area Served
3.6 Key Players Sanger’s Sequencing Service Product Solution and Service
3.7 Date of Enter into Sanger’s Sequencing Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sanger’s Sequencing Service Breakdown Data by Type (2015-2026)
4.1 Global Sanger’s Sequencing Service Historic Market Size by Type (2015-2020)
4.2 Global Sanger’s Sequencing Service Forecasted Market Size by Type (2021-2026)
5 Sanger’s Sequencing Service Breakdown Data by Application (2015-2026)
5.1 Global Sanger’s Sequencing Service Historic Market Size by Application (2015-2020)
5.2 Global Sanger’s Sequencing Service Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Sanger’s Sequencing Service Market Size (2015-2026)
6.2 North America Sanger’s Sequencing Service Market Size by Type (2015-2020)
6.3 North America Sanger’s Sequencing Service Market Size by Application (2015-2020)
6.4 North America Sanger’s Sequencing Service Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Sanger’s Sequencing Service Market Size (2015-2026)
7.2 Europe Sanger’s Sequencing Service Market Size by Type (2015-2020)
7.3 Europe Sanger’s Sequencing Service Market Size by Application (2015-2020)
7.4 Europe Sanger’s Sequencing Service Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Sanger’s Sequencing Service Market Size (2015-2026)
8.2 China Sanger’s Sequencing Service Market Size by Type (2015-2020)
8.3 China Sanger’s Sequencing Service Market Size by Application (2015-2020)
8.4 China Sanger’s Sequencing Service Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Sanger’s Sequencing Service Market Size (2015-2026)
9.2 Japan Sanger’s Sequencing Service Market Size by Type (2015-2020)
9.3 Japan Sanger’s Sequencing Service Market Size by Application (2015-2020)
9.4 Japan Sanger’s Sequencing Service Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Sanger’s Sequencing Service Market Size (2015-2026)
10.2 Southeast Asia Sanger’s Sequencing Service Market Size by Type (2015-2020)
10.3 Southeast Asia Sanger’s Sequencing Service Market Size by Application (2015-2020)
10.4 Southeast Asia Sanger’s Sequencing Service Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Source BioScience (UK)
11.1.1 Source BioScience (UK) Company Details
11.1.2 Source BioScience (UK) Business Overview
11.1.3 Source BioScience (UK) Sanger’s Sequencing Service Introduction
11.1.4 Source BioScience (UK) Revenue in Sanger’s Sequencing Service Business (2015-2020))
11.1.5 Source BioScience (UK) Recent Development
11.2 GenScript Biotech Corporation (US)
11.2.1 GenScript Biotech Corporation (US) Company Details
11.2.2 GenScript Biotech Corporation (US) Business Overview
11.2.3 GenScript Biotech Corporation (US) Sanger’s Sequencing Service Introduction
11.2.4 GenScript Biotech Corporation (US) Revenue in Sanger’s Sequencing Service Business (2015-2020)
11.2.5 GenScript Biotech Corporation (US) Recent Development
11.3 Thermo Fisher Scientific, Inc. (US)
11.3.1 Thermo Fisher Scientific, Inc. (US) Company Details
11.3.2 Thermo Fisher Scientific, Inc. (US) Business Overview
11.3.3 Thermo Fisher Scientific, Inc. (US) Sanger’s Sequencing Service Introduction
11.3.4 Thermo Fisher Scientific, Inc. (US) Revenue in Sanger’s Sequencing Service Business (2015-2020)
11.3.5 Thermo Fisher Scientific, Inc. (US) Recent Development
11.4 LGC Science Group Limited (UK)
11.4.1 LGC Science Group Limited (UK) Company Details
11.4.2 LGC Science Group Limited (UK) Business Overview
11.4.3 LGC Science Group Limited (UK) Sanger’s Sequencing Service Introduction
11.4.4 LGC Science Group Limited (UK) Revenue in Sanger’s Sequencing Service Business (2015-2020)
11.4.5 LGC Science Group Limited (UK) Recent Development
11.5 Fasteris SA (Switzerland)
11.5.1 Fasteris SA (Switzerland) Company Details
11.5.2 Fasteris SA (Switzerland) Business Overview
11.5.3 Fasteris SA (Switzerland) Sanger’s Sequencing Service Introduction
11.5.4 Fasteris SA (Switzerland) Revenue in Sanger’s Sequencing Service Business (2015-2020)
11.5.5 Fasteris SA (Switzerland) Recent Development
11.6 CeMIA SA (Greece)
11.6.1 CeMIA SA (Greece) Company Details
11.6.2 CeMIA SA (Greece) Business Overview
11.6.3 CeMIA SA (Greece) Sanger’s Sequencing Service Introduction
11.6.4 CeMIA SA (Greece) Revenue in Sanger’s Sequencing Service Business (2015-2020)
11.6.5 CeMIA SA (Greece) Recent Development
11.7 Quintara Biosciences (US)
11.7.1 Quintara Biosciences (US) Company Details
11.7.2 Quintara Biosciences (US) Business Overview
11.7.3 Quintara Biosciences (US) Sanger’s Sequencing Service Introduction
11.7.4 Quintara Biosciences (US) Revenue in Sanger’s Sequencing Service Business (2015-2020)
11.7.5 Quintara Biosciences (US) Recent Development
11.8 GenHunter Corporation (US)
11.8.1 GenHunter Corporation (US) Company Details
11.8.2 GenHunter Corporation (US) Business Overview
11.8.3 GenHunter Corporation (US) Sanger’s Sequencing Service Introduction
11.8.4 GenHunter Corporation (US) Revenue in Sanger’s Sequencing Service Business (2015-2020)
11.8.5 GenHunter Corporation (US) Recent Development
11.9 GENEWIZ (US)
11.9.1 GENEWIZ (US) Company Details
11.9.2 GENEWIZ (US) Business Overview
11.9.3 GENEWIZ (US) Sanger’s Sequencing Service Introduction
11.9.4 GENEWIZ (US) Revenue in Sanger’s Sequencing Service Business (2015-2020)
11.9.5 GENEWIZ (US) Recent Development
11.10 Nucleics (Australia)
11.10.1 Nucleics (Australia) Company Details
11.10.2 Nucleics (Australia) Business Overview
11.10.3 Nucleics (Australia) Sanger’s Sequencing Service Introduction
11.10.4 Nucleics (Australia) Revenue in Sanger’s Sequencing Service Business (2015-2020)
11.10.5 Nucleics (Australia) Recent Development
11.11 SciGenom Labs Pvt. Limited (Inida)
10.11.1 SciGenom Labs Pvt. Limited (Inida) Company Details
10.11.2 SciGenom Labs Pvt. Limited (Inida) Business Overview
10.11.3 SciGenom Labs Pvt. Limited (Inida) Sanger’s Sequencing Service Introduction
10.11.4 SciGenom Labs Pvt. Limited (Inida) Revenue in Sanger’s Sequencing Service Business (2015-2020)
10.11.5 SciGenom Labs Pvt. Limited (Inida) Recent Development
11.12 Microsynth AG. Inc. (Germany)
10.12.1 Microsynth AG. Inc. (Germany) Company Details
10.12.2 Microsynth AG. Inc. (Germany) Business Overview
10.12.3 Microsynth AG. Inc. (Germany) Sanger’s Sequencing Service Introduction
10.12.4 Microsynth AG. Inc. (Germany) Revenue in Sanger’s Sequencing Service Business (2015-2020)
10.12.5 Microsynth AG. Inc. (Germany) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sanger’s Sequencing Service Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Diagnostics
1.2.3 Biomarkers & Cancer
1.2.4 Reproductive Health
1.2.5 Personalized Medicine
1.2.6 Forensics
1.2.7 Others
1.3 Market by Application
1.3.1 Global Sanger’s Sequencing Service Market Share by Application: 2020 VS 2026
1.3.2 Academic & Government Research Institutes
1.3.3 Pharmaceutical Companies
1.3.4 Biotechnology Companies
1.3.5 Hospitals & Clinics
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Sanger’s Sequencing Service Market Perspective (2015-2026)
2.2 Global Sanger’s Sequencing Service Growth Trends by Regions
2.2.1 Sanger’s Sequencing Service Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Sanger’s Sequencing Service Historic Market Share by Regions (2015-2020)
2.2.3 Sanger’s Sequencing Service Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sanger’s Sequencing Service Players by Market Size
3.1.1 Global Top Sanger’s Sequencing Service Players by Revenue (2015-2020)
3.1.2 Global Sanger’s Sequencing Service Revenue Market Share by Players (2015-2020)
3.2 Global Sanger’s Sequencing Service Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Sanger’s Sequencing Service Revenue
3.4 Global Sanger’s Sequencing Service Market Concentration Ratio
3.4.1 Global Sanger’s Sequencing Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sanger’s Sequencing Service Revenue in 2019
3.5 Key Players Sanger’s Sequencing Service Area Served
3.6 Key Players Sanger’s Sequencing Service Product Solution and Service
3.7 Date of Enter into Sanger’s Sequencing Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sanger’s Sequencing Service Breakdown Data by Type (2015-2026)
4.1 Global Sanger’s Sequencing Service Historic Market Size by Type (2015-2020)
4.2 Global Sanger’s Sequencing Service Forecasted Market Size by Type (2021-2026)
5 Sanger’s Sequencing Service Breakdown Data by Application (2015-2026)
5.1 Global Sanger’s Sequencing Service Historic Market Size by Application (2015-2020)
5.2 Global Sanger’s Sequencing Service Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Sanger’s Sequencing Service Market Size (2015-2026)
6.2 North America Sanger’s Sequencing Service Market Size by Type (2015-2020)
6.3 North America Sanger’s Sequencing Service Market Size by Application (2015-2020)
6.4 North America Sanger’s Sequencing Service Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Sanger’s Sequencing Service Market Size (2015-2026)
7.2 Europe Sanger’s Sequencing Service Market Size by Type (2015-2020)
7.3 Europe Sanger’s Sequencing Service Market Size by Application (2015-2020)
7.4 Europe Sanger’s Sequencing Service Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Sanger’s Sequencing Service Market Size (2015-2026)
8.2 China Sanger’s Sequencing Service Market Size by Type (2015-2020)
8.3 China Sanger’s Sequencing Service Market Size by Application (2015-2020)
8.4 China Sanger’s Sequencing Service Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Sanger’s Sequencing Service Market Size (2015-2026)
9.2 Japan Sanger’s Sequencing Service Market Size by Type (2015-2020)
9.3 Japan Sanger’s Sequencing Service Market Size by Application (2015-2020)
9.4 Japan Sanger’s Sequencing Service Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Sanger’s Sequencing Service Market Size (2015-2026)
10.2 Southeast Asia Sanger’s Sequencing Service Market Size by Type (2015-2020)
10.3 Southeast Asia Sanger’s Sequencing Service Market Size by Application (2015-2020)
10.4 Southeast Asia Sanger’s Sequencing Service Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Source BioScience (UK)
11.1.1 Source BioScience (UK) Company Details
11.1.2 Source BioScience (UK) Business Overview
11.1.3 Source BioScience (UK) Sanger’s Sequencing Service Introduction
11.1.4 Source BioScience (UK) Revenue in Sanger’s Sequencing Service Business (2015-2020))
11.1.5 Source BioScience (UK) Recent Development
11.2 GenScript Biotech Corporation (US)
11.2.1 GenScript Biotech Corporation (US) Company Details
11.2.2 GenScript Biotech Corporation (US) Business Overview
11.2.3 GenScript Biotech Corporation (US) Sanger’s Sequencing Service Introduction
11.2.4 GenScript Biotech Corporation (US) Revenue in Sanger’s Sequencing Service Business (2015-2020)
11.2.5 GenScript Biotech Corporation (US) Recent Development
11.3 Thermo Fisher Scientific, Inc. (US)
11.3.1 Thermo Fisher Scientific, Inc. (US) Company Details
11.3.2 Thermo Fisher Scientific, Inc. (US) Business Overview
11.3.3 Thermo Fisher Scientific, Inc. (US) Sanger’s Sequencing Service Introduction
11.3.4 Thermo Fisher Scientific, Inc. (US) Revenue in Sanger’s Sequencing Service Business (2015-2020)
11.3.5 Thermo Fisher Scientific, Inc. (US) Recent Development
11.4 LGC Science Group Limited (UK)
11.4.1 LGC Science Group Limited (UK) Company Details
11.4.2 LGC Science Group Limited (UK) Business Overview
11.4.3 LGC Science Group Limited (UK) Sanger’s Sequencing Service Introduction
11.4.4 LGC Science Group Limited (UK) Revenue in Sanger’s Sequencing Service Business (2015-2020)
11.4.5 LGC Science Group Limited (UK) Recent Development
11.5 Fasteris SA (Switzerland)
11.5.1 Fasteris SA (Switzerland) Company Details
11.5.2 Fasteris SA (Switzerland) Business Overview
11.5.3 Fasteris SA (Switzerland) Sanger’s Sequencing Service Introduction
11.5.4 Fasteris SA (Switzerland) Revenue in Sanger’s Sequencing Service Business (2015-2020)
11.5.5 Fasteris SA (Switzerland) Recent Development
11.6 CeMIA SA (Greece)
11.6.1 CeMIA SA (Greece) Company Details
11.6.2 CeMIA SA (Greece) Business Overview
11.6.3 CeMIA SA (Greece) Sanger’s Sequencing Service Introduction
11.6.4 CeMIA SA (Greece) Revenue in Sanger’s Sequencing Service Business (2015-2020)
11.6.5 CeMIA SA (Greece) Recent Development
11.7 Quintara Biosciences (US)
11.7.1 Quintara Biosciences (US) Company Details
11.7.2 Quintara Biosciences (US) Business Overview
11.7.3 Quintara Biosciences (US) Sanger’s Sequencing Service Introduction
11.7.4 Quintara Biosciences (US) Revenue in Sanger’s Sequencing Service Business (2015-2020)
11.7.5 Quintara Biosciences (US) Recent Development
11.8 GenHunter Corporation (US)
11.8.1 GenHunter Corporation (US) Company Details
11.8.2 GenHunter Corporation (US) Business Overview
11.8.3 GenHunter Corporation (US) Sanger’s Sequencing Service Introduction
11.8.4 GenHunter Corporation (US) Revenue in Sanger’s Sequencing Service Business (2015-2020)
11.8.5 GenHunter Corporation (US) Recent Development
11.9 GENEWIZ (US)
11.9.1 GENEWIZ (US) Company Details
11.9.2 GENEWIZ (US) Business Overview
11.9.3 GENEWIZ (US) Sanger’s Sequencing Service Introduction
11.9.4 GENEWIZ (US) Revenue in Sanger’s Sequencing Service Business (2015-2020)
11.9.5 GENEWIZ (US) Recent Development
11.10 Nucleics (Australia)
11.10.1 Nucleics (Australia) Company Details
11.10.2 Nucleics (Australia) Business Overview
11.10.3 Nucleics (Australia) Sanger’s Sequencing Service Introduction
11.10.4 Nucleics (Australia) Revenue in Sanger’s Sequencing Service Business (2015-2020)
11.10.5 Nucleics (Australia) Recent Development
11.11 SciGenom Labs Pvt. Limited (Inida)
10.11.1 SciGenom Labs Pvt. Limited (Inida) Company Details
10.11.2 SciGenom Labs Pvt. Limited (Inida) Business Overview
10.11.3 SciGenom Labs Pvt. Limited (Inida) Sanger’s Sequencing Service Introduction
10.11.4 SciGenom Labs Pvt. Limited (Inida) Revenue in Sanger’s Sequencing Service Business (2015-2020)
10.11.5 SciGenom Labs Pvt. Limited (Inida) Recent Development
11.12 Microsynth AG. Inc. (Germany)
10.12.1 Microsynth AG. Inc. (Germany) Company Details
10.12.2 Microsynth AG. Inc. (Germany) Business Overview
10.12.3 Microsynth AG. Inc. (Germany) Sanger’s Sequencing Service Introduction
10.12.4 Microsynth AG. Inc. (Germany) Revenue in Sanger’s Sequencing Service Business (2015-2020)
10.12.5 Microsynth AG. Inc. (Germany) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
